These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


543 related items for PubMed ID: 28145607

  • 1. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N, Morishita K, Ohta H, Takiguchi M.
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [Abstract] [Full Text] [Related]

  • 2. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
    Caivano D, Rishniw M, Birettoni F, Patata V, Giorgi ME, Porciello F.
    J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124
    [Abstract] [Full Text] [Related]

  • 3. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
    Morgan KRS, Monteith G, Raheb S, Colpitts M, Fonfara S.
    Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
    Vereb M, Atkins CE, Adin D, Blondel T, Coffman M, Lee S, Guillot E, Ward JL.
    J Vet Intern Med; 2024 Sep; 38(1):51-60. PubMed ID: 37909399
    [Abstract] [Full Text] [Related]

  • 5. Assessment of Left Atrial Deformation and Function by 2-Dimensional Speckle Tracking Echocardiography in Healthy Dogs and Dogs With Myxomatous Mitral Valve Disease.
    Baron Toaldo M, Romito G, Guglielmini C, Diana A, Pelle NG, Contiero B, Cipone M.
    J Vet Intern Med; 2017 May; 31(3):641-649. PubMed ID: 28455877
    [Abstract] [Full Text] [Related]

  • 6. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH.
    J Vet Intern Med; 2012 May; 26(1):76-84. PubMed ID: 22151356
    [Abstract] [Full Text] [Related]

  • 7. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure.
    Tidholm A, Ljungvall I, Höglund K, Westling AB, Häggström J.
    J Vet Intern Med; 2009 May; 23(6):1197-207. PubMed ID: 19909428
    [Abstract] [Full Text] [Related]

  • 8. QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.
    Brüler BC, Jojima FS, Dittrich G, Giannico AT, Sousa MG.
    J Vet Cardiol; 2018 Aug; 20(4):254-266. PubMed ID: 30031743
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary-vein-to-pulmonary-artery ratio can be utilized to evaluate myxomatous mitral valve disease progression in dogs.
    Kim MS, Kim J, Seo MW, Park C.
    Am J Vet Res; 2024 Jul 01; 85(7):. PubMed ID: 38663446
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 Jul 01; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 11. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
    Dickson D, Caivano D, Matos JN, Summerfield N, Rishniw M.
    J Vet Cardiol; 2017 Dec 01; 19(6):469-479. PubMed ID: 29111284
    [Abstract] [Full Text] [Related]

  • 12. Radial and longitudinal strain and strain rate assessed by speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
    Zois NE, Tidholm A, Nägga KM, Moesgaard SG, Rasmussen CE, Falk T, Häggström J, Pedersen HD, Åblad B, Nilsen HY, Olsen LH.
    J Vet Intern Med; 2012 Dec 01; 26(6):1309-19. PubMed ID: 23113772
    [Abstract] [Full Text] [Related]

  • 13. Anatomic regurgitant orifice area obtained using 3D-echocardiography as an indicator of severity of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Müller S, Menciotti G, Borgarelli M.
    J Vet Cardiol; 2017 Oct 01; 19(5):433-440. PubMed ID: 28964709
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease.
    Malcolm EL, Visser LC, Phillips KL, Johnson LR.
    J Am Vet Med Assoc; 2018 Oct 15; 253(8):1038-1045. PubMed ID: 30272515
    [Abstract] [Full Text] [Related]

  • 15. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Oct 15; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 16. Rate of left ventricular pressure change by Doppler echocardiography in dogs with chronic mitral valve disease at different stages of congestive heart failure.
    Kim YH, Choi GJ, Park C.
    Vet Radiol Ultrasound; 2018 Nov 15; 59(6):758-766. PubMed ID: 30184293
    [Abstract] [Full Text] [Related]

  • 17. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ, Ljungvall I, Hillström A, Møller JE, Hagman R, Falk T, Höglund K, Häggström J, Olsen LH.
    Vet J; 2016 Mar 15; 209():113-8. PubMed ID: 26831162
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.
    Baron Toaldo M, Romito G, Guglielmini C, Diana A, Pelle NG, Contiero B, Cipone M.
    J Vet Intern Med; 2018 May 15; 32(3):914-921. PubMed ID: 29572938
    [Abstract] [Full Text] [Related]

  • 19. Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.
    Poser H, Berlanda M, Monacolli M, Contiero B, Coltro A, Guglielmini C.
    J Vet Cardiol; 2017 Jun 15; 19(3):228-239. PubMed ID: 28579307
    [Abstract] [Full Text] [Related]

  • 20. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S, Green D, Christley R, Dukes-McEwan J.
    J Vet Cardiol; 2019 Jun 15; 23():21-31. PubMed ID: 31174726
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.